Cardiovascular effects of peptides related to the enkephalins and β-casomorphin

Schmidt, 1933, J. Pharmacol. Ex. Ther., 47, 411

Eckenhoff, 1960, Clin. Pharmacol. Ther., 1, 483

Fennessy, 1971, Eur. J. Pharmacol., 14, 1, 10.1016/0014-2999(71)90116-6

Stein, 1976, Arch. Inter. Pharmacodyn. Therap., 223, 54

Lemaire, 1978, 75, 6240

Henschen, 1979

Takagi, 1979, Eur. J. Pharmacol., 55, 109, 10.1016/0014-2999(79)90154-7

Dixon, 1965, Amer. Stat. Assn., 60, 967, 10.2307/2283398

P. Bolme, K. Fuxe, L.F. Agnati, R. Bradley and J. Symthies, Eur. J. Pharmacol. 48 319-324.

Gomes, 1977, Arch. Pharmacol., 294, 547

Roemer, 1977, Nature, 268, 547, 10.1038/268547a0

Drew, 1946, Anesthesiology, 7, 44, 10.1097/00000542-194601000-00007

Lowenstein, 1969, N. Engl. J. Med., 281, 1389, 10.1056/NEJM196912182812503

Feldberg, 1979, J. Physiol. (London), 275, 57P

Eyster, 1912, Heart, 4, 59

Gohkale, 1963, Brit. J. Pharmacol., 21, 273

Kosterlitz, 1964, Brit. J. Pharmacol. Chemother., 22, 499, 10.1111/j.1476-5381.1964.tb01704.x

Hughes, 1977, Brit. J. Pharmacol., 61, 639, 10.1111/j.1476-5381.1977.tb07557.x

Lundberg, 1979, Gastroenterol., 77, 468, 10.1016/0016-5085(79)90006-4

Atweh, 1977, Brain Res., 124, 53, 10.1016/0006-8993(77)90863-0

McAllen, 1976, J. Physiol. (London), 258, 187, 10.1113/jphysiol.1976.sp011414

Robbins, 1939, J. Pharmacol. Exp. Ther., 66, 216

Laubie, 1974, Eur. J. Pharmacol., 28, 66, 10.1016/0014-2999(74)90113-7